Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
9,209,680
-
Share change
-
-1,548,896
-
Total reported value
-
$35,277,813
-
Put/Call ratio
-
265%
-
Price per share
-
$3.83
-
Number of holders
-
68
-
Value change
-
-$6,501,402
-
Number of buys
-
28
-
Number of sells
-
37
Institutional Holders of ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) as of Q1 2020
As of 31 Mar 2020,
ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,209,680 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., ETF MANAGERS GROUP, LLC, Portolan Capital Management, LLC, STATE STREET CORP, ZEKE CAPITAL ADVISORS, LLC, AdvisorShares Investments LLC, Prentice Capital Management, LP, NORTHERN TRUST CORP, and Mirae Asset Global Investments Co., Ltd..
This page lists
68
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.